Our Markets

The Prosthetics Product Market

Prosthetics include artificial limbs and related products for people who were born with limb loss or limb difference, or who have had limbs amputated. Through the Össur and College Park brands, we provide a full range of premium lower and upper limb prosthetics, including feet, knees, hands, fingers, liners, and other components.

The size of the global prosthetics product market is estimated to be approximately USD 1.6-1.8 billion. Embla Medical is the second largest company operating in Prosthetics with a market share estimated at 24-26%. The growth rate of the market is estimated to be 5-7%.

Growth in the prosthetics industry is driven by volume and mix with a consistent renewal and maintenance cycle for prosthetic products, increasing fitting rates for prosthetics patients, increasing reimbursement coverage, new innovative technologies being accepted for reimbursement, and increasing healthcare coverage and disposable income in emerging markets. The primary sales channel in the prosthetics market is Orthotic & Prosthetic clinics (Patient Care clinics).

Pricing in the prosthetics product market is on average relatively stable with yearly pricing adjustments due to inflationary trends but also influenced by regional specific developments in reimbursement.

The Neuro Orthotics Product Market

Neuro orthotics include products for people suffering from stroke, spinal cord injuries, multiple sclerosis, cerebral palsy or other neurological conditions. Through the Fior & Gentz brand, we provide a full range of premium orthotic joints for custom ankle foot orthoses and knee ankle foot orthoses.

The size of the global neuro orthotics product market that Embla Medical operates in is estimated to be approximately USD 400-500 million and Embla Medical’s market share is estimated at 4-6%. The growth rate of the market is estimated to be 10-12%.

Growth in the neuro orthotics industry is driven by volume and mix with a consistent renewal and maintenance cycle, increasing fitting rates, increasing reimbursement coverage, new innovative technologies being accepted for reimbursement and increasing healthcare coverage.

Pricing in the neuro orthotics product market is on average relatively stable with yearly pricing adjustments due to inflationary trends but also influenced by regional specific developments in reimbursement.

The Bracing & Supports Product Market

Bracing & Supports include products used to provide support for therapeutic and preventative purposes. Through the Össur brand we provide a comprehensive line of products with primary focus on osteoarthritis and injury solutions including devices supporting the spine, knee, hip, foot, ankle, and hands.

The size of the global Bracing & Supports product market that Embla Medical operates in is estimated to be approximately USD 2.8-3.0 billion and Embla Medical’s market share is estimated at 5-7%. The growth rate of the market is estimated to be 2-3%.

Market growth is driven by healthy volume growth. Increased amateur sports and activity levels, increased volumes of elective surgeries such as knee replacement surgeries, that drive demand for postoperative bracing solutions, and the utilization of high-end innovative products such as the Unloader® OA bracing products, support market growth in Bracing & Supports. The primary sales channel in the bracing & supports market is Orthotic & Prosthetic clinics (Patient Care clinics), hospitals, and orthopaedic clinics. Price levels are relatively stable with yearly pricing adjustments due to inflationary trends but also influenced by regional specific developments in reimbursement, but for some markets, there is moderate price pressure for selected product categories, mainly products of a lower innovation level.

The Patient Care Market

The Patient Care market consists of patient care clinics, often referred to as Orthotic & Prosthetic clinics or O&P clinics, that provide services to patients with orthotic & prosthetic mobility challenges.

The size of the global Patient Care service market is estimated to be approximately USD 14-15 billion. Embla Medical is estimated to be the third or fourth largest company operating in the market with a market share estimated at 2-3%. The growth rate of the market is estimated to be 3-5%.

Growth in the Patient Care service market is driven by volume and mix with a consistent renewal and maintenance cycle, increasing fitting rates for orthotics & prosthetics patients, increasing reimbursement coverage, new innovative technologies being accepted for reimbursement, and increasing healthcare coverage and disposable income in emerging markets. Pricing in the market is determined by regional specific reimbursement systems and is on average limited to moderate. Selected markets increase reimbursement rates up to inflationary levels, while most markets have limited rate adjustments.

Orthopaedic Industry Stakeholders

In the orthopaedic industry, many stakeholders and decision makers are involved in the purchasing decision. Stakeholders can be categorized into five groups.

Industry Trends Create Opportunities

Economic development around the world and global macrotrends create demand and opportunities for growth.

We have selected six trends that have a positive impact on demand for Embla Medical‘s products and services:.